Skip to Content

Notice

Agency Information Collection Activities; Proposed Collection; Comment Request; Experimental Study on Consumer Responses to Labeling Statements on Food Packages

Document Details

Information about this document as published in the Federal Register.

Enhanced Content

Relevant information about this document from Regulations.gov provides additional context. This information is not part of the official Federal Register document.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

AGENCY:

Food and Drug Administration, HHS.

ACTION:

Notice.

SUMMARY:

The Food and Drug Administration (FDA) is announcing an opportunity for public comment on the proposed collection of certain information by the Agency. Under the Paperwork Reduction Act of 1995 (the PRA), Federal Agencies are required to publish notice in the Federal Register concerning each proposed collection of information and to allow 60 days for public comment in response to the notice. This notice solicits comments on a study entitled “Experimental Study on Consumer Responses to Labeling Statements on Food Packages.”

DATES:

Submit either electronic or written comments on the collection of information by June 13, 2011.

ADDRESSES:

Submit electronic comments on the collection of information to http://www.regulations.gov. Submit written comments on the collection of information to the Division of Dockets Management (HFA-305), Food and Drug Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852. All comments should be identified with the docket number found in brackets in the heading of this document.

Start Further Info

FOR FURTHER INFORMATION CONTACT:

Denver Presley, Office of Information Management, Food and Drug Administration, 1350 Piccard Dr., PI50-400B, Rockville, MD 20850, 301-796-3793.

End Further Info End Preamble Start Supplemental Information

SUPPLEMENTARY INFORMATION:

Under the PRA (44 U.S.C. 3501-3520), Federal Agencies must obtain approval from the Office of Management and Budget (OMB) for each collection of information they conduct or sponsor. “Collection of information” is defined in 44 U.S.C. 3502(3) and 5 CFR 1320.3(c) and includes Agency requests or requirements that members of the public submit reports, keep records, or provide information to a third party. Section 3506(c)(2)(A) of the PRA (44 U.S.C. 3506(c)(2)(A)) requires Federal Agencies to provide a 60-day notice in the Federal Register concerning each proposed collection of information before submitting the collection to OMB for approval. To comply with this requirement, FDA is publishing notice of the proposed collection of information set forth in this document.

With respect to the following collection of information, FDA invites comments on these topics: (1) Whether the proposed collection of information is necessary for the proper performance of FDA's functions, including whether the information will have practical utility; (2) the accuracy of FDA's estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; (3) ways to enhance the quality, utility, and clarity of the information to be collected; and (4) ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques, when appropriate, and other forms of information technology.

Experimental Study on Consumer Responses to Labeling Statements on Food Packages; 21 U.S.C. 393(d)(2)(C)—(OMB 0910-NEW)

I. Background

The Nutrition Labeling and Education Act requires almost all packaged foods to bear nutrition labeling in the form of the Nutrition Facts label. The law also allows manufacturers to provide other nutrition information on labels in the form of various types of statements, including claims, as long as such statements comply with the regulatory limits that govern the use of each type of statement. There are three types of Start Printed Page 20676claims that the food industry can voluntarily use on food labels: (1) Health claims, (2) nutrient content claims (e.g., “Low fat”), and (3) structure/function claims (e.g., “Calcium builds strong bones.”). There are three types of health claims: (1) Those that meet the Significant Scientific Standard (e.g., “Adequate calcium and Vitamin D throughout life, as part of a well-balanced diet, may reduce the risk of osteoporosis.”), (2) those that are based on authoritative statements from a recognized scientific body of the U.S. government or the National Academy of Sciences (e.g., “Diets containing foods that are a good source of potassium and that are low in sodium may reduce the risk of high blood pressure and stroke.”), and (3) qualified health claims that are granted under enforcement discretion (e.g., “Supportive but not conclusive research shows that consumption of EPA and DHA omega-3 fatty acids may reduce the risk of coronary heart disease. One serving of [Name of the food] provides [ ] grams of EPA and DHA omega-3 fatty acids. [See nutrition information for total fat, saturated fat, and cholesterol content.]”). Although the different types of claims are regulated differently, they all must be truthful and not misleading (Ref. 1).

With the increased public interest in identifying healthier foods, U.S. food processors have been adding nutritional information in the form of nutrition symbols to food labels in addition to claims. Examples of nutrition symbols that have been or are planned to be used on food labels include nutrient-specific disclosure (e.g., “Guideline Daily Amounts”) (Ref. 2), calorie declaration (Ref. 3), summary product rating (e.g., “Smart Spot”) (Ref. 4), and a hybrid summary indicator with nutrient-specific disclosure (e.g., “Sensible Solution: Good Source of Calcium, Good Sources of 8 Vitamins and Minerals”) (Ref. 5). Claims related to non-nutritional product characteristics are also used in food labeling. The claims may feature, among other things, statements about how foods are grown or made (e.g., “Organic” and “All Natural”) or absence of a substance (e.g., “Gluten-free”).

Many consumers use claims and the Nutrition Facts label in food choice decisions (Refs. 6 through 8). While some products carry only a single labeling statement (e.g., either one claim or one symbol) on their packages, many products carry two or more labeling statements. In addition, on the same package the attributes of one statement may differ from those of other statements in terms of featured nutrient, type of claim, framing of statement, nature of statement, and presentation of statement. For example, a package may display one or more statements such as symbols relating to nutrition content, statements in words relating to the presence of certain nutrients, statements in words relating to the absence of other nutrients, statements in words relating the health benefits of consuming foods containing or not containing certain other nutrients, and statements in words describing how the product was produced. Moreover, all of those symbols and statements are distributed in various places on the package in different font sizes and colors.

There exists a large body of literature on the impacts of different types of labeling statements on consumer perceptions and choices of products (Refs. 9 and 10). The majority of the research, including the consumer research that the Agency has previously conducted (Refs. 11 and 12), has focused on single labeling statements by eliciting study participants' reactions to variants of a given statement. An advantage of this research approach is that it helps isolate the effects of individual statements and avoid potential confounding effects caused by the presence of other statements. A disadvantage of this research approach, however, is that it does not necessarily reflect the labels consumers see in the marketplace. In particular, the existing literature provides little information about how the coexistence of two or more different labeling statements affects product perceptions and choices. This information, however, is critical for understanding the roles played by labeling statements in dietary decisions.

Research suggests consumer product perceptions and purchase decisions can be influenced by labeling statements and different labeling statements may have different influences (Refs. 9 through 12). Therefore, the FDA, as part of its effort to promote public health, proposes to use this study to explore consumer responses to food labels that bear multiple labeling statements. Specifically, the study plans to examine: (1) Consumer responses to food labels that exhibit various combinations of the characteristics of labeling statements (i.e., nutrients, types of claim, framing of statement, nature of statement, and presentation of statement), (2) whether and how consumer responses to one of the characteristics may be affected by other characteristics (i.e., the interactions between different characteristics of labeling statements), and (3) whether and how labeling statements affect the use of the Nutrition Facts label.

The proposed collection of information is a controlled randomized experimental study. The study will use a 15-minute Web-based survey to collect information from 4,000 English-speaking adult members of an online consumer panel maintained by a contractor. The study will aim to produce a sample that reflects the U.S. Census on gender, education, age, and ethnicity/race.

The study will randomly assign each of its participants to view two label images from a set of food labels that will be created for the study and systematically varied in the (1) number of statements (none, one, or two); (2) featured nutrient and substance (e.g., fat, sodium, sugars, fiber, whole grain, calories, antioxidant vitamins, or allergen); (3) type of statement (text or graphic, specifically the Guideline Daily Amounts nutrition symbol); (4) framing of statement (“good source of,” “low,” or “free”); (5) nature of statement (nutrition or method of production such as “natural”); (6) type size of statement (large or small); and (7) featured product (e.g., snacks, breakfast cereals, breads, soups, or frozen meals). With regard to claims, the study will focus on examples of nutrient content claims and structure/function claims, which can be found on many food packages (Ref. 13). All label images will be mock-ups resembling food labels that may be found in the marketplace. Images will show product identity (e.g., potato chips), but not any real or fictitious brand name. The study will provide interested participants access to the Nutrition Facts label, but not together with a product image.

The survey will ask its participants to view label images and answer questions about their perceptions and reactions related to the viewed product and label. Product perceptions (e.g., healthiness, potential health benefits, levels of nutrients and substances, taste, and safety) and label perceptions (e.g., helpfulness and credibility) will constitute the measures of responses in the experiment. To help understand the data, the survey will also collect information about participants' background, such as consumption, purchase, perception, and familiarity with a category of food; awareness and knowledge of nutrients and substances; dietary interests; motivation regarding label use and health literacy; and health status and demographic characteristics.

The study is part of the Agency's continuing effort to enable consumers to make informed dietary choices and construct healthful diets. Results of the study will be used primarily to enrich the Agency's understanding of how Start Printed Page 20677multiple claims and other labeling statements on food packages may affect how consumers perceive a product or a label, which may in turn affect their dietary choices. Results of the study will not be used to develop population estimates.

To help design and refine the questionnaire, FDA plans to conduct cognitive interviews by screening 72 panelists in order to obtain 9 participants in the interviews. Each screening is expected to take 5 minutes (0.083 hour) and each cognitive interview is expected to take 1 hour. The total for cognitive interview activities is 15 hours (6 hours + 9 hours). Subsequently, we plan to conduct pretests of the questionnaire before it is administered in the study. We expect that 1,600 invitations, each taking 2 minutes (0.033 hour), will need to be sent to panelists to have 200 of them complete a 15-minute (0.25 hour) pretest. The total for the pretest activities is 106 hours (53 hours + 50 hours). For the survey, we estimate that 32,000 invitations, each taking 2 minutes (0.033 hour) to complete, will need to be sent to the consumer panel to have 3,000 of its members complete a 15-minute (0.25 hour) questionnaire. The total for the survey activities is 2,056 hours (1,056 hours + 1,000 hours). Thus, the total estimated burden is 2,174 hours. FDA's burden estimate is based on prior experience with research that is similar to this proposed study.

FDA estimates the burden of this collection of information as follows:

Table 1—Estimated Annual Reporting Burden 1

Portion of studyNumber of respondentsNumber of responses per respondentTotal annual responsesAverage burden per response (in hours)Total hours
Cognitive interview screener721725/606
Cognitive interview91919
Pretest invitation1,60011,6002/6053
Pretest200120015/6050
Survey invitation32,000132,0002/601,056
Survey4,00014,00015/601,000
Total2,174
1 There are no capital costs or operating and maintenance costs associated with this collection of information.

II. References

The following references have been placed on display in the Division of Dockets Management (see ADDRESSES) and may be seen by interested persons between 9 a.m. and 4 p.m., Monday through Friday. (FDA has verified the Web site addresses, but we are not responsible for any subsequent changes to the Web site after this document publishes in the Federal Register.)

1. U.S. Food and Drug Administration. Claims That Can Be Made for Conventional Foods and Dietary Supplements. September 2003. Available at http://www.fda.gov/​Food/​LabelingNutrition/​LabelClaims/​ucm111447.htm.

2. Kellogg's. Nutrition at a Glance. 2010. Available at http://www.kelloggnutrition.com/​learn-about-labels/​nutrition-at-a-glance.html.

3. PepsiCo. Nutrition Labeling. 2010. Available at http://www.pepsico.com/​Purpose/​Human-Sustainability/​Nutrition-Labeling.html.

4. Schmit, J. “PepsiCo Labels Some of Its Products `Smart,'” USA Today, September 2, 2004. Available at http://www.usatoday.com/​money/​industries/​food/​2004-09-02-smart-spot_​x.htm.

5. Kraft Foods. Sensible Solution. 2010. Available at http://www.kraftrecipes.com/​kf/​HealthyLiving/​SensibleSolution/​SensibleSolution_​Landing.aspx.

6. Centers for Disease Control and Prevention. 2005-2006 National Health and Examination Survey questionnaire, Diet Behavior and Nutrition section. Unpublished results of questions DBQ.750 and DBQ.780. Questionnaire is available at http://www.cdc.gov/​nchs/​data/​nhanes/​nhanes_​05_​06/​sp_​dbq_​d.pdf.

7. U.S. Food and Drug Administration. 2008 Health and Diet Survey. March 20, 2010. Available at http://www.fda.gov/​Food/​ScienceResearch/​ResearchAreas/​ConsumerResearch/​ucm193895.htm.

8. Food Marketing Institute. 2009 U.S. Grocery Shopper Trends Survey. Washington, DC 2009.

9. Drichoutis, A.C., Lazaridis, P. and Nayga, R.M., “Consumers' Use of Nutritional Labels: a Review of Research Studies and Issues,” Academy of Marketing Science Review, 2006(9), 2006. Available at http://www.amsreview.org/​articles/​drichoutis09-2006.pdf.

10. Lähteenmäki, L., Lampila, P.. Grunert, K., Boztug, Y., Ueland, Ø., Åström, A. and Martinsdóttir, E., “Impact of Health-Related Claims on the Perception of Other Product Attributes,” Food Policy, 23: 230-9. 2010.

11. Labiner-Wolfe, J., Lin, C.-T. J. and Verrill L., “Effect of Low Carbohydrate Claims on Consumer Perceptions about Food Products' Healthfulness and Helpfulness for Weight Management,” Journal of Nutrition Education and Behavior, 42(5): 315-320, 2010.

12. Roe, B., Levy, A.S., and Derby, B.M., “The Impact of Health Claims on Consumer Search and Product Evaluation Outcomes: Evidence from FDA Experimental Data,” Journal of Public Policy and Marketing, 18(1): 89-105, 1999.

13. LeGault, L., Brandt, M.B., McCabe, N., Adler, C., Brown, A.-M., and Brecher, S., “2000-2001 Food Label and Package Survey: An Update on Prevalence of Nutrition Labeling and Claims on Processed, Packaged Foods,” Journal of the American Dietetic Association, 104(6): 952-8, 2004.

Start Signature

Dated: April 8, 2011.

Leslie Kux,

Acting Assistant Commissioner for Policy.

End Signature End Supplemental Information

[FR Doc. 2011-8908 Filed 4-12-11; 8:45 am]

BILLING CODE 4160-01-P